Patent · US Active

Methods of administering 3,4-diaminopridine

US11873525B2 · kind B2 · utility

0Cited by
12References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2023
Grant dateJan 16, 2024
Priority date—
Expiry dateMay 23, 2043

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods of determining NAT acetylation status of a subject with a 3,4-DAP-sensitive disease, methods of selecting a dose of 3,4-DAP or a pharmaceutically acceptable salt thereof adjusted to a subject's acetylation status, methods of administering 3,4-diaminopyridine or a pharmaceutically acceptable salt thereof to a patient in need thereof, and methods of treating 3,4-DAP sensitive diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.